Location:Home /  Resource
Past list
Massively Parallel Sequencing for SARS-CoV-2 Detection and Surveillance
Release date:2021-07-01Writer:MGIViews:2599Share

As the COVID-19 pandemic continues to evolve, more and more sequencing power is needed to obtain the most up-to-date information on the virus. This information help to construct the transmission routes and the profiles of the most recent variants, effectively supporting large-scale surveillance efforts and research on different mutations of the virus.


Why Massively Parallel Sequencing (MPS)?
·Detect co-infection and secondary infection
·Provide first-hand information without prior pathogen information
·Full-length genome information for virus source and mutation monitoring

Dr. Yao Jiang, MGI senior product manager

If you have any questions, you can send an email to:
  • Hotline (Global)
  • Email
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2024 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies